个人简介

罗宸，博士，住院医师，毕业于复旦大学临床医学（八年制），师从复旦大学附属华山医院神经外科吴劲松教授。主要从事脑胶质瘤的创新诊疗研究及临床转化，及脑肿瘤专病库建设。以第一（含共同第一作者）在Neurosurgery、Journal of Neurosurgery、Journal of Neuroinflammation等杂志发表文章9篇。以Sub-I身份执行前瞻性、多中心临床试验（干预性、诊断性）共10项，其中4项已结题，6项进行中。申请发明专利3项，授权2项，转化1项（合同金额300万元），申请软件著作权1项，获上海市优秀创新银奖等奖项；以编写秘书/作者身份参与撰写专著2部。

研究方向

脑胶质瘤创新诊疗研究及临床转化

代表性论著

1. The Efficacy and Safety of Sub-lobectomy on Glioblastoma: A Propensity Score-Weighted Study. J Neurosurgery, Accepted 2025
2. Luo C, Song K, Wu S, et al. The prognosis of glioblastoma: a large, multifactorial study. Br J Neurosurg. 2021;35(5):555-561.
3. 罗宸,吴帅,吴劲松.分子病理指导下的脑胶质瘤手术的研究进展[J].中华神经外科杂志, 2021, 37(9):5.
4. Wei P, Wang K, Luo C, et al. Cordycepin confers long-term neuroprotection via inhibiting neutrophil infiltration and neuroinflammation after traumatic brain injury. J Neuroinflammation. 2021;18(1):137.
5. Wang P, Luo C, Hong PJ, Rui WT, Wu S. The Role of Surgery in IDH-Wild-Type Lower-Grade Gliomas: Threshold at a High Extent of Resection Should be Pursued. Neurosurgery. 2021;88(6):1136-1144.
6. Wu S, Luo C, Li F, Hameed NUF, Jin Q, Zhang J. Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway. Cancer Cell Int. 2019; 19:314.
7. Wu S, Luo C, Hameed NUF, Wang Y, Zhuang D. UCP2 silencing in glioblastoma reduces cell proliferation and invasiveness by inhibiting p38 MAPK pathway. Exp Cell Res. 2020;394(1):112110.
8. Xie X, Luo C, Wu S, et al. Recursive partitioning analysis for survival stratification and early imaging prediction of molecular biomarker in glioma patients. BMC Cancer. 2024;24(1):818.
9. Xiong Z, Luo C, Wang P, et al. The Intraoperative Utilization of Multimodalities Could Improve the Prognosis of Adult Glioblastoma: A Single-Center Observational Study. World Neurosurg. 2022;165: e532-e545.